By Kathleen Gallagher and Mark Johnson, Milwaukee Journal Sentinel
Cellular Dynamics International Inc. said Thursday it has been granted a U.S. patent on the automated production of cells that can be grown into any of the more than 200 types of cells in the body.
The patent positions the Madison company, which makes human cells in industrial quantities, as the leading supplier of choice for scientists seeking a high-quality, reliable supply of human cells to use for research into new drugs and therapies, and stem cell banking, executives said.
“We believe that automation is critical to both large-scale manufacture of human stem cells and differentiated cell types, and their application, especially in cellular therapeutics,” said Bob Palay, chief executive officer of the company, which is known as CDI.
CDI makes iPS, or human induced pluripotent stem cells and tissue cells. Like embryonic stem cells, these powerful cells can be grown into any of the body’s cell types.
The patent becomes part of a robust portfolio of more than 800 that CDI has been awarded, has pending or has licensed. Read more …